Trastuzumab (Anti-HER2) Recombinant Antibody – Functional Grade
Price range: $600.00 through $15,000.00
Humanized monoclonal IgG1 antibody targeting HER2 (ERBB2)
Description
Trastuzumab is a humanized monoclonal IgG1 antibody that targets the HER2 (ERBB2) receptor, which is overexpressed in certain cancer types. Binding to HER2 modulates receptor activity and downstream signaling pathways, making trastuzumab a commonly used reference antibody in oncology and receptor biology studies.
Additional information
| Source | DrugBank DB00072 |
|---|---|
| Buffer | PBS pH 7.4 |
| Reactivity | Human |
| Immunogen | Recombinant human HER2 (ERBB2) |
| Isotype | IgG1 |
| Application | ELISA, WB |
| Heavy Chain Sequence | EVQLVESGGGLVQPGGSLRLSCAASGFNIKDTYIHWVRQAPGKGLEWVARIYPTNGYTRY |
| Light Chain Sequence | DIQMTQSPSSLSASVGDRVTITCRASQDVNTAVAWYQQKPGKAPKLLIYSASFLYSGVPS |
| Format | Liquid |
| Endotoxins | Endotoxin Free |
| Notes | For research use only. Not suitable for clinical or therapeutic use. |
| Delivery Time | 3-5 days if in stock; 3-5 weeks if out of stock |
| Stability and Storage | Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term. Avoid repeated freeze-thaw cycles. |
| Synonyms et alternative names | Anti-HER2, anti-ERBB2, anti-Human Epidermal Growth Factor Receptor 2 |
| Reference Product | Herceptin® (trastuzumab) Herceptin® is a registered trademark of Genentech, Inc. This product is not affiliated with, endorsed by, or manufactured by Genentech, Inc. or Roche. |


